I am a molecular biologist and Postdoctoral Research Scholar at Arizona State University, where I work in Dr. David Brafman’s laboratory. I earned my Ph.D. in Biological Sciences from the University at Buffalo in 2023 under the mentorship of Dr. Zhen Q. Wang. During my doctoral research, I focused on bioengineering E. coli to produce plant-derived terpenes, using metabolic and genetic engineering to understand and optimize the production of valuable biological compounds. I also contributed to research investigating plant compounds such as cardenolides and the biosynthesis of digoxin, which resulted in publications in journals including Nature Communications, Plant and Cell Physiology, and Applied Microbiology and Biotechnology.

Following my Ph.D., I transitioned from plant biotechnology and microbial engineering into biomedical and neuroscience research. My current work at ASU focuses on developing human induced pluripotent stem cell (hiPSC)-based models to study Alzheimer’s disease, including the biological mechanisms underlying sex-based differences in disease susceptibility. My research journey has allowed me to combine molecular biology, genetic engineering, metabolic engineering, and stem-cell research across different areas of biology. I am particularly interested in applying these interdisciplinary approaches to better understand complex human diseases and ultimately contribute to advances in biomedical research.

[email protected]